Clinovi Research Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 02-11-2024
- Paid Up Capital ₹ 4.57 Cr
as on 02-11-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.28 Cr
as on 02-11-2024
- Revenue 185.44%
(FY 2023)
- Profit 7.44%
(FY 2023)
- Ebitda 104.29%
(FY 2023)
- Net Worth -44.14%
(FY 2023)
- Total Assets -1.05%
(FY 2023)
About Clinovi Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.57 Cr.
The company currently has active open charges totaling ₹2.28 Cr.
Rajesh Kumar and Radhika Inapakolla serve as directors at the Company.
- CIN/LLPIN
U73200PN2021PTC199123
- Company No.
199123
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Clinovi Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Kumar  | Director | 04-Mar-2021 | Current |
| Radhika Inapakolla | Director | 04-Mar-2021 | Current |
Financial Performance of Clinovi Research.
Clinovi Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 185.44% increase. The company also saw a slight improvement in profitability, with a 7.44% increase in profit. The company's net worth observed a substantial decline by a decrease of 44.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clinovi Research?
In 2023, Clinovi Research had a promoter holding of 76.67% and a public holding of 23.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Sep 2021 | ₹2.28 Cr | Open |
How Many Employees Work at Clinovi Research?
Clinovi Research has a workforce of 30 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clinovi Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinovi Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
